Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Lionel Apétoh; François Ghiringhelli; Antoine Tesnière; Michel Obéid; Carla Ortiz; Alfredo Criollo; Grégoire Mignot; Maria Chiara Maiuri; Evelyn Ullrich; Patrick Saulnier; Huan Yang; Sebastián Amigorena; Bernard Ryffel; Franck J. Barrat; Paul Säftig; Françis Lévi; Rosette Lidereau; Catherine Noguès; Jean‐Paul Mira; Agnès Chompret; V. Joulin; Françoise Clavel‐Chapelon; Jean Bourhis; Fabrice André; Suzette Delaloge; Thomas Tursz; Guido Guido Kroemer; Laurence Zitvogel

doi:10.1038/nm1622

Related publications

Article2010

Chemotherapy and radiotherapy: Cryptic anticancer vaccines

Yuting Ma, Oliver Kepp, François Ghiringhelli, Lionel Apétoh, Laetitia Aymeric, Clara Locher, Antoine Tesnière, Isabelle Martins, André Ly, Nicole M. Haynes, Mark J. Smyth, Guido Guido Kroemer, Laurence Zitvogel

Chapter in a book2013

miRNAs That Shape the Innate Immune System: Regulation through Toll-Like Receptor Signaling

Annie M. Curtis, Luke O'neill

Article2004

Signal transduction by the lipopolysaccharide receptor, Toll‐like receptor‐4

Eva M. Pålsson‐McDermott, Luke O'neill

Immunology

Article2004

Contribution of Toll-like Receptor 9 Signaling to the Acute Inflammatory Response to Nonviral Vectors

Hongmei Zhao, Hiraoki Hemmi, Akira Shizuo, Seng H. Cheng, Ronald K. Scheule, Nelson S. Yew

Molecular Therapy

Article2006

Limited contribution of Toll-like receptor 2 and 4 to the host response to a fungal infectious pathogen,<i>Cryptococcus neoformans</i>

Kiwamu Nakamura, Kazuya Miyagi, Yoshinobu Koguchi, Yuki Kinjo, Kaori Uezu, Takeshi Kinjo, Morikazu Akamine, Jiro Fujita, Ikuo Kawamura, Masao Mitsuyama, Yoshiyuki Adachi, Naohito Ohno, Kiyoshi Takeda, Akira Shizuo, Akiko Miyazato, Mitsuo Kaku, Kazuyoshi Kawakami

FEMS Immunology & Medical Microbiology